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INTRODUCTION
Systemic lupus erythematosus (SLE) is cryptogenic autoim-
mune disease, and may give rise to multiple organ damage
because of immune complex deposits. The 52,452 patients were
registered in Ministry of Health, Labour and Welfare in Japan
at the end of 2002. In that registry, the morbidity of SLE is
estimated with 8-10 per 100,000 in our country, the ratio of
the man and woman is 1:9-10, and the age at onset tends to
be 20-40 yr old.
The renal involvement in SLE is so called ‘lupus nephritis’
and 50-80% of patients with SLE suffer from lupus nephri-
tis. According to the report for The Japanese Society for Dial-
ysis Therapy, the number of patients with SLE who develop
end-stage renal failure requiring dialysis is recognized around
300 each year in our country, and lupus nephritis is one of
major causes of morbidity and mortality in SLE. The various
clinical manifestations are recognized in patients with lupus
nephritis, for example, asymptomatic microhematuria, nephrot-
ic syndrome and rapidly progressive glomerulonephritis. It
is generally considered that renal biopsy is performed when
there are urinary abnormal findings or renal dysfunction and
that renal pathologists and nephrologists evaluate the degree
of histological damages to structure therapeutic plans for lupus
nephritis.
A new classification was suggested under the support of
International Society of Nephrology/Renal Pathology Society
(ISN/PRS) in 2003. We will give an outline of this new clas-
sification, describe consideration from literature for the new
classification, and evaluate the association between the new
classification and renal outcome.
The problems for old classifications and the details of
new classification
From 1964, the classifications for lupus nephritis have been
revised repeatedly regarding identification and definition of
various lesions, and a revised WHO classification was proposed
in 1982. However, this classification were pointed out many
problems; 1) it did not give a definition of quantitative and
qualitative evaluation, 2) interobserver reproducibility was not
good, 3) the association between histological lesions and clini-
cal findings was open to question, 4) manuscripts using this
classification were not submitted. In addition, Najafi et al. (1) re-
ported that segmental necrotic lesions observed in more than
50% of glomeruli in WHO class III were associated with poor
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Usefulness of ISN/RPS Classification of Lupus Nephritis
About 50-80% of patients with lupus suffer from lupus nephritis which is one of major
causes of morbidity and mortality. Renal pathologists and nephrologists should eval-
uate the degree of histological damages to establish therapeutic plans for lupus nephri-
tis. In order to standardize definitions, to emphasize clinically relevant lesions, and
to improve interobserver reproducibility, the International Society of Nephrology/Renal
Pathology Society (ISN/RPS) classification was proposed. Recently, several retro-
spective validation studies concerning the utility of the ISN/RPS classification, espe-
cially among class IV, were performed. In these reports, reproducibility is improved
by the definition of diagnostic term, but the outcome related with classification, espe-
cially in class IV, is controversial. We performed retrospective analysis of 99 biop-
sy-proven subjects with lupus nephritis in our facility using the ISN/RPS classifica-
tion. The class IV-G group tended to exhibit a worse renal outcome, but the differ-
ence compared with IV-S was not significant. In a Cox proportional hazards mod-
els, Independent histological predictors of poor renal outcome were extracapillary
proliferation, glomerular sclerosis and fibrous crescents, while hyaline thrombi and
fibrous adhesions were of favorable renal outcome. Both were similarly observed
in IV-G and IV-S. The more qualitative categorization by the response to standard
treatment may be needed to emphasize clinically relevant lesion related to renal
outcome.
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� REVIEW�renal outcome, and renal outcome in their group was worse
than in diffuse proliferative nephritis in WHO class IV.
In 2002, an international group of pathologists, nephrol-
ogists, and rheumatologists convened to formulate a new clas-
sification of lupus nephritis. In order to standardize definitions,
to emphasize clinically relevant lesions, and to improve inter-
observer reproducibility, the ISN/RPS 2003 classification was
proposed and published in Kidney International and Journal
of the American Society of Nephrology (2, 3).
ISN/RPS classification
The ISN/RPS classification are given in Table 1, the defi-
nition for diagnostic terms are given in Table 2, and the param-
eters of activity and chronicity are given in Table 3. Overall,
it bears a strong similarity to the 1974 WHO classification
due to simplicity, but introduces several modifications con-
cerning quantitative and qualitative differences between class
III and IV lesions. This classification is based on glomerular
pathology, so the significant vascular and tubulointerstitial
pathology should be reported as separate entries. The points
of ISN/RPS classification are shown below.
Class I
It is defined as minimal mesangial lupus nephritis with
mesangial accumulation of immune complexes identified by
immunofluorescence (or electron microscopy). A complete
lack of renal abnormality by light microscopy, immunofluo-
rescence, and electron microscopy (WHO Ia) is excluded from
this classification.
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I Minimal mesangial lupus glomerulonephritis (LGN)
II Mesangial proliferative LGN 
III Focal LGN (<50% of the total number of glomeruli)
III (A) Purely active: focal proliferative LGN
III (A/C) Active and chronic
III (C) Chronic: focal sclerosing LGN
IV Diffuse segmental (IV-S) or global (IV-G) LGN (50% or more of the total number of glomeruli)
IV-S (A) or IV-G (A): diffuse segmental or global proliferative LGN
IV-S (A/C) or IV-G (A/C)
IV-S (C) or IV-G (C): diffuse segmental or global sclerosing LGN 
V Membranous LGN
VI Advanced sclerotic LGN (>90% of glomeruli globally sclerosed without residual activity): end stage LGN
Table 1. ISN/RPS 2003 classification of lupus nephritis
Diffuse: A lesion involving most (≥50%) glomeruli
Focal: A lesion involving most (<50%) glomeruli
Global: A lesion involving more than half of the glomerular tuft
Segmental: A lesion involving less than half of the glomerular tuft (i.e. at least half of the glomerular tuft is spared)
Mesangial hypercellularity: At least three mesangial cells per mesangial region in a 3 micron thick section
Endocapillary proliferation: Endocapillary hypercellularity due to increased number of mesangial cells, endothelial cells, and infiltrating monocytes, 
and causing narrowing of the glomerular capillary lumina
Extracapillary proliferation or cellular crescent: Extracapillary cell proliferation of more than two cell layers occupying one fourth or more of the
glomerular capsular circumference
Karyorrhexis: Presence of apoptotic, pyknotic, and fragmented nuclei
Necrosis: A lesion characterized by fragmentation of nuclei disruption of the glomerular basement membrane, often associated with the presence of
fibrin-rich material
Hyaline thrombi: Intracapillary eosinophiric material of a homogeneous consistency by which immunofluorescence has been shown to consist
of immune deposits
Proportion of involved glomeruli: Intended to indicate the percentage of total glomeruli affected by lupus nephritis, including the glomeruli that are
sclerosed due to lupus nephritis, but excluding ischemic glomeruli with inadequate perfusion due to vascular pathology separate from lupus nephritis
Table 2. The definition for diagnostic terms
Active lesions
Endocapillary hypercellularity with or without leukocyte infiltration
and with substantial luminal reduction
Karyorrhexis
Fibrinoid necrosis
Rupture of glomerular basement membrane
Crescents, cellular or fibrocellular
Subendothelial deposits identifiable by light microscopy
(wireloops)
Intraluminal immune arregates (hyaline thrombi)
Chronic lesions
Glomerular sclerosis (segmental, global)
Fibrous adhesions
Fibrous crescents
Table 3. Active and chronic glomerular lesionsClass II
It is defined as mesangial proliferative lupus nephritis. The
purely mesangial hypercellularity was excluded from param-
eters of activity in this classification, so the presence of any
active or chronic lesions is incompatible with class II. 
Class III
It is defined as focal lupus nephritis involving less than
50% of all glomeruli. In assessing the extent of the lesions,
glomeruli with both active and sclerotic lesions are taken to
account. Class III was found to be almost segmental and rarely
global in pilot study, so it was not divided into subclasses.
Class IV
It is defined as diffuse lupus nephritis involving more than
50% of all glomeruli. This class is subdivided into diffuse seg-
mental lupus nephritis (class IV-S) when >50% of the involved
glomeruli have segmental lesions, and diffuse global lupus
nephritis (class IV-G) when >50% of the involved glomeruli
have global lesions. The rare examples of extesive subendothe-
lial glomerular deposits with almost no proliferation should
be included in this category. 
In this classification, parameters of activity and chronicity
are defined. In the diagnostic line, active lesions (A), active and
chronic lesions (A/C), or chronic lesions (C) should be noted.
In assessing the extent of the lesions, both active and
chronic lesions will be taken into account.
Class V
It is defined as membranous lupus nephritis with global or
segmental continuous granular subepithelial deposits (involv-
ing >50% of the tuft of >50% of the glomeruli by microscopy
or immunofluorescence). When a membranous lesion is asso-
ciated with the active or chronic lesions of class III or IV, both
diagnoses are to be reported in the diagnostic line. 
Class VI
It is defined as advanced-stage lupus nephritis involving
>90% global glomerulosclerosis. There should be no evidence
of active lesions. 
Validation studies of ISN/RPS classification of lupus
nephritis
Recently, several retrospective validation studies concern-
ing utility of ISN/RPS classification, especially among class
IV, were performed. 
Furness et al. (4) reported that a significant improvement in
interobserver reproducibility was demonstrated by the new
classification and reproducibility of the assessment of disease
activity and chronicity remains suboptimal. Hence Groot-
scholten et al. (5) showed both ISN/RPS classification and WHO
1995 classification showed low agreement with intraclass cor-
relations coefficients. Although it is difficult to explain this
discrepancy, we sometimes hesitate to diagnose histological
findings of glomeruli with both active and chronic change,
especially in repeated biopsy specimens. The modifications
by treatments or time course may decrease reproducibility.
Yokoyama et al. (6) revealed that class IV in ISN/RPS clas-
sification serves as a significant risk factor for the renal out-
come, but not category IV in WHO classification. They also
showed no statistic difference in renal outcome between Class
IV-S and Class IV-G. They pointed out that qualitative changes
including necrosis may be important factor for the renal out-
come.
Hill et al. (7) also reported no difference in renal outcomes
defined as serum creatinine doubling between IV-S and IV-
G for 10 yr follow up. Additionally they founded that patients
with class IV-G lesions had greater overall immune deposits
and subendothelial deposits on IF and greater hyaline deposits
on light microscopy, and patients with class IV-S showed pre-
dominant mesangial deposits and a much higher rate of gl-
omerular fibrinoid necrosis. They concluded that these lesions
may have a different pathogenesis.
Schwartz et al. (8) reported that WHO classification into
severe segmental lesions and into diffuse global lesions are not
congruent with ISN/RPS IV-S and IV-G. They concluded
that the ISN/RPS minimizes pathological and outcome dif-
ferences between classes IV-S and IV-G which results in the
loss of informational content from the renal biopsies. In the
ISN/RPS classification, IV-G includes severe chronic lesions
such as global glomerulosclerosis and active lesions such as
wireloops that may have a good treatment response. These
may be reason why no difference related to renal outcome was
seen between IV-S and IV-G.
Kim et al. (9) evaluate the response to intravenous cyclophos-
phamide therapy in patients with class IV-G and class IV-S
lupus nephritis patients. They showed higher remission rate
in patients with IV-S than patients with IV-G. In this report,
the pathological profiles including glomerular sclerosis, cel-
lular crescent and interstitial fibrosis did not differ between
IV-G and IV-S. Justly, the IV-S group had predominantly seg-
mental endocapillary proliferation and the IV-G group had
predominantly global endocapillary proliferation. The other
histological findings (karyorrhexis, fibrinoid necrosis, wireloops,
hyaline thrombi, etc) were not shown. Although relationship
between each histological findings and treatment response
is not evaluated in this report, qualitative varieties between
IV-S and IV-G may affect the treatment response or renal prog-
nosis.
Hiramatsu et al. evaluated 92 patients with lupus nephri-
tis according to ISN/RPS classification related with renal out-
comes. They found that the renal function was more likely
to deteriorate in class IV-G cases than class IV-S cases, but
difference was not significant. In subcategorical analysis in
IV-G cases, patients with active lesion alone (IV-G [A]) res-
ponded well to treatment and patients and renal function of
class IV-G (A) cases maintained. Although histological dis-
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chronic lesions seemed to affect the renal outcomes as said
previously (10).
Derivation study for histological predictors of renal 
outcome in our facility
We performed retrospective analysis of 99 biopsy-proven
subjects with lupus nephritis in our facility from 1990 to 2006
using the ISN/RPS classification. The prevalence of each cate-
gory was as follows: class I 3%, class II 13%, class III 9%, class
IV-S 20%, class IV-G 46%, class V 8% and class VI 1%. The
class IV-G group tended to exhibit a worse renal outcome
defined as 1.5 times elevations of creatinine, but the differ-
ence was not significant. We evaluated active or chronic find-
ings quantitatively and made the score of each lesions. Among
class III, IV-S, and IV-G, endocapillary proliferation score was
significantly higher in class IV-G than in class III, and wire-
loop lesions were more remarkable in class IV-G than class III
and IV-S. The other glomerular scores were similar among
each class. Independent histological predictors of poor renal
outcome were extracapillary proliferation, glomerular sclerosis
and fibrous crescents analyzed by Cox proportional hazards
model, while independent histological predictors of favorable
renal outcome were hyaline thrombi and fibrous adhesions.
In our study, no statistical difference between IV-S and IV-
G were found as both favorable and poor renal outcome pre-
dictors. Several limitations of this study should be noted. In
this study, only 14 patients reached the primary endpoint.
CONCLUSION
We reviewed essence of ISN/RPS classification of lupus ne-
phritis and recent validation study related with classification.
The interobserver reproducibility was improved in this clas-
sification mostly. The more qualitative categorization by the
response to standard treatment may be needed to emphasize
clinically relevant lesion related to renal outcome.
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